In the case of a DNA vaccine that may co-transfect APC and tumor cells, this adjuvant could be, for example, a TNF-α encoding gene, promoting DC activation by engaging TNF receptor 2 [69,70]. The gene discussed is TNF; the disease is neoplasm.